DIABETES AND SMALLER HEIGHT AS INDEPENDENT RISK FACTORS OF ACCESS SITE COMPLICATIONS IN TAVI  by Mitsuhashi, Hirotsugu et al.
Valvular Heart Disease
E1991
JACC March 27, 2012
Volume 59, Issue 13
DIABETES AND SMALLER HEIGHT AS INDEPENDENT RISK FACTORS OF ACCESS SITE COMPLICATIONS 
IN TAVI
ACC Moderated Poster Contributions
McCormick Place South, Hall A
Sunday, March 25, 2012, 9:30 a.m.-10:30 a.m.
Session Title: TAVR: Real World Outcomes and Potential Complications
Abstract Category: 11. Valvular Heart Disease: Therapy
Presentation Number: 1151-284
Authors: Hirotsugu Mitsuhashi, Sam Radhakrishnan, Stephen Fremes, University of Toronto Sunnybrook Health Science Centre, Toronto, Canada
Background: Risk factors for access site complications in trans-catheter aortic valve implantation (TAVI) is not well known.
Methods: 82 consecutive patients who underwent trans-femoral (n = 78) or trans-subclavian (n = 4 ) TAVI are included in this study. Self 
expandable valves were used in 4 cases and balloon expandable valves in 76. 1 patient died before valve implantation and the procedure was 
aborted in 1 case because of mismatch of the valve. Balloon expandable 14Fr sheaths (n = 6) or standard 18/19Fr sheaths (n = 76 ) were used 
in all patients. Percutaneous femoral access with a closure device was used in 30 cases and arterial cut down was used in 52 cases. Loading 
dose of Aspirin and Clopidogrel were given before procedure and intravenous heparin was used during the procedure to prevent thromboembolic 
events. Access site artery diameter, calcification and tortuosity were assessed by CT angiogram. Annulus size was determined by transesophageal 
echocardiogram. Ejection fraction and left ventricular size were measured with trans-thoracic echocardiogram. Access site complication was defined 
as access site vascular injury which needed unplanned surgical/interventional repair or bleeding/hematoma which needed blood transfusion. Odds 
ratios (ORs) and their 95% confidence intervals (CIs) were calculated with univariable and multivariate logistic regression analysis and risk factors of 
access site complications were determined.
Results: Access site complication was observed in 11 patients (13.4%). Vascular injury was observed in 8 patients (9.8%), bleeding/hematoma 
observed in 6 patients (7.3%) while 3 patients (3.7%) had both. Only smaller height and a history of diabetes were significant predictors for access 
site complications by univariate analysis (OR: 1.12; 95%CI: 1.03-1.22, P = 0.007 and OR: 4.48; 95%CI: 1.20-16.7, P = 0.026, respectively) and 
after adjustment for other variables (OR: 1.14; 95% CI: 1.04-1.25, P = 0.007 and OR: 5.77; 95%CI: 1.30-25.6, P = 0.021, respectively). 
Conclusion: Only smaller height and diabetes were independent risk factors for access site complications in TAVI.
